Contact PI/Project LeaderROUPHAEL, NADINE GEORGES Other PIs
Awardee OrganizationEMORY UNIVERSITY
Description
Abstract Text
Abstract
In an era marked by unprecedented global health challenges, the development and deployment of effective and
safe vaccines stand as the best countermeasure against infectious diseases. The field of vaccinology stands at
the intersection of many disciplines (microbiology, immunology, infectious diseases, public health, pathology,
pediatrics, medicine, epidemiology, behavior, global health, implementation science, engineering, bioinformatics,
and health policy) and plays a pivotal role in safeguarding the well-being of communities worldwide. The demand
for transformative research and comprehensive training in vaccinology has never been more pressing. This is a
renewal application for the fourth cycle (years 16-20) of the established Emory Vaccinology Training Program
T32 (VTP-T32). Since 2009, our program continues to be uniquely positioned to train a cadre of basic,
translational, public health and clinical scientists with cutting edge, multi-disciplinary expertise in vaccinology.
The program supports skilled and diverse post-doctoral fellows through rigorous didactic coursework, hands on
mentored project and professional development. Mentored by highly accomplished faculty, fellows will engage
in innovative research from one of seven Research Training Sections: 1) Pathogenesis & Vaccine Discovery; 2)
Immunology; 3) Translation, Delivery and Clinical Trials; 4) Epidemiology; 5) Implementation Science & Health
Policy; 6) Vaccine Safety (a dedicated CDC funded slot); and 7) Bioinformatics and Computational Vaccinology.
We will continue to build on our success: 94% of graduates have stayed in government, industry or academia
and among them, 87% are thriving in vaccine-related fields. A total of 186 papers are directly associated with
the VTP-T32 and 40% of these papers are with trainees as first author; in addition, a total of 145 grants from a
variety of funding sources have been awarded to our scholars.
The specific aims of the Emory VTP-T32 are:
1- To continue implementing our systematic approach for identifying, recruiting and retaining highly qualified,
motivated, and diverse post-doctoral trainees into the VTP-T32.
2- To provide each trainee a rigorous and tailored curriculum covering key aspects of vaccinology, a robust hands-
on mentored research project, and career mentoring.
3- To continue integrating the strong basic science, translational research, implementation science, clinical trials,
and vaccine policy programs at Emory into a multi-faceted training experience and inclusive environment
promoting collaborations and interdisciplinary approaches.
Public Health Relevance Statement
Narrative
The Emory VTP-T32 addresses the urgent need for training the next generation of vaccinologists. Vaccines have
dramatically reduced the burden of infectious diseases, shown great potential for preventing and controlling
conditions, and often are highly cost-effective. However, to achieve the full potential of vaccines and address
difficulties that have hindered progress, a new generation of well-prepared scientists continues to be needed.
National Institute of Allergy and Infectious Diseases
CFDA Code
855
DUNS Number
066469933
UEI
S352L5PJLMP8
Project Start Date
01-August-2009
Project End Date
31-August-2029
Budget Start Date
01-September-2024
Budget End Date
31-August-2025
Project Funding Information for 2024
Total Funding
$435,985
Direct Costs
$441,976
Indirect Costs
$32,358
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Allergy and Infectious Diseases
$435,985
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 2T32AI074492-16
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 2T32AI074492-16
Patents
No Patents information available for 2T32AI074492-16
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 2T32AI074492-16
Clinical Studies
No Clinical Studies information available for 2T32AI074492-16
News and More
Related News Releases
No news release information available for 2T32AI074492-16
History
No Historical information available for 2T32AI074492-16
Similar Projects
No Similar Projects information available for 2T32AI074492-16